BusinessCann
BusinessCann · page 18
- Press releases
SOMAÍ Pharmaceuticals awarded €2.7M in funding from Portugal 2020 Grant
SOMAÍ Pharmaceuticals Unipessoal LDA has received an innovative products grant of 2.7 million euros by the Portugal 2020 committee.
- News
Irish Clinical Establishment Continues To Shun Cannabis Leaving Medical Access Programme Doomed to Failure
Drug policy specialist Natalie O’Regan on Ireland’s faltering Medical Cannabis Access Programme THE Medical Cannabis Access Programme (MCAP) was launched in 2017, four years later and the first product is now being made available for patients.
- Press releases
Health House Announces Start Of Germany-Wide Study On The Effect Of Cannabis Extracts
HEALTH House International Ltd (ASX:HHI) has announced the commencement of a non- interventional observational study in Germany examining the effect of its own-branded cannabis extracts on quality of life of patients and their safety and tolerability.
- Uncategorized
Gesundheitshaus kündigt Start einer bundesweiten Studie zur Wirkung von Cannabisextrakten an
HEALTH House International Ltd(ASX:HHI) hat den Beginn einer nicht-interventionellen Beobachtungsstudie in Deutschland angekündigt, die die Wirkung seiner eigenen Cannabisextrakte auf die Lebensqualität von Patienten und ihre Sicherheit und Verträglichkeit untersucht.
- CBD Market
Fourfive Adds Fraser Group And Next To Growing Physical And Online Presence
FOURFIVE, a CBD and wellness brand loved by athletes and those leading an active lifestyle, today confirmed that it has secured a number of tier one retail listings.
- Press releases
LYPHE Group Opens Registration To Patient Representative Board
IN an industry first, LYPHE is bringing patients to the table to explore how to improve the patient experience across the organisation – and the wider industry.
- Hemp Industry
Why Is Hemp Still Being Politically Sidelined When It Is The Solution To Deforestation?
Rebekah Shaman, Managing Director of the British Hemp Alliance, with an update from COP26 COP26 is probably the most important meeting this decade.
- Press releases
Aurora Cannabis Acquires Significant Equity Stake In Growery BV – One Of 10 Successful Applicants For A Cannabis Production Licence In The Netherlands
Aurora Cannabis Inc (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced that Aurora Nederland B.V., a wholly owned indirect subsidiary of the Company, has entered into an agreement to invest in a significant equity stake in Netherlands-based Growery B.V. one of the few license holders entitled to participate in the Controlled…
- Press releases
Alphagreen Group Accelerates Its Aggregator Strategy With Launch Of NUOPTIMA Amazon Management Services
NEXT-GEN Health and Wellness e-commerce platform Alphagreen Group has added another asset to its growth and incubation service arm NUOPTIMA.
- Press releases
Pharma C Invests In Product Earth Expo
Pharma C Investments (AQSE: PCIL), an early-stage investor and venture builder in the medical cannabis industry with a particular focus on ancillary businesses, is pleased to announce that it has completed its first investment in a company called Product Earth Expo UK Limited (“Product Earth”).
- Press releases
FoliuMed Seals White Label Cannabis Deals In South America
FoliuMed, a medical cannabis company with manufacturing operations in Germany and cultivation in South America, recently concluded two major sales agreements with customers in Brazil and Colombia.
- Press releases
Creso Pharma To Expand Into Burgeoning Swiss Medicinal Cannabis Market
Creso Pharma Ltd (ASX:CPH, OTCQB:COPHF) has launched efforts to enter the expanding Swiss cannabis market, with a non-binding Letter of Intent (LOI) forming the first overture to Innuana AG Switzerland, a local licensed cannabis grower, to grow and market medicinal cannabis in the Swiss market on Creso’s behalf.
